NEU 0.35% $20.17 neuren pharmaceuticals limited

Ann: Results of Phase 2 trial in moderate to severe TBI-NEU.AX, page-9

  1. 194 Posts.
    The US army has paid for most of the TBI trials and the company has invested shareholders funds in Rett and Fragile X so that is now the way forward. Disappointing but not the end for NEU
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.